1. IgG Responses to tissue-associated antigens as biomarkers of immunological treatment efficacy
- Author
-
Smith, Heath A., Maricque, Brett B., Eberhardt, John, Petersen, Benjamin, Gulley, James L., Schlom, Jeffrey, and McNeel, Douglas G.
- Subjects
Prostate cancer -- Care and treatment -- Research ,Antigens -- Health aspects -- Research ,Immunoglobulin G -- Physiological aspects -- Research ,Biological markers -- Research ,Biotechnology industry ,High technology industry - Abstract
We previously demonstrated that IgG responses to a panel of 126 prostate tissue-associated antigens are common in patients with prostate cancer. In the current report we questioned whether changes in IgG responses to this panel might be used as a measure of immune response, and potentially antigen spread, following prostate cancer-directed immune-active therapies. Sera were obtained from prostate cancer patients prior to and three months following treatment with androgen deprivation therapy (n = 34), apoxviral vaccine (n = 31), and a DNA vaccine (n = 21). Changes in IgG responses to individual antigens were identified by phage immunoblot. Patterns of IgG recognition following three months of treatment were evaluated using a machine-learned Bayesian Belief Network (ML-BBN). We found that different antigens were recognized following androgen deprivation compared with vaccine therapies. While the number of clinical responders was low in the vaccine-treated populations, we demonstrate that ML-BBN can be used to develop potentially predictive models., 1. Introduction Over the last two decades many new immunotherapy approaches to the treatment of cancer have entered clinical development due to the increased understanding of the mechanisms of antigen [...]
- Published
- 2011
- Full Text
- View/download PDF